Abstract:
PURPOSE: A novel biomarker of serological diagnosis of Crohn's disease is provided to analyze serological relation with M. paratuberculosis and specifically react to serum from Crohn's disease patient. CONSTITUTION: An antigen for diagnosing Crohn's disease is derived from Mycobacterium avium subsp. Paratuberculosis isolated from human and specifically reacts with serum of Crohn's disease patient. A method for isolating the antigen for diagnosing Crohn's disease comprises: a step of detecting protein which specifically reacts with IgG of Crohn's disease patient using pooling serum(n=10) with Mycobacterium Paratuberculosis secretion antigen, and cell extract antigen from human; a step of identifying protein which specifically reacts to the Crohn's disease patient through LC-ESI-MS method; a step of analyzing protein through matching score and bioinformatic analysis; and a step of an identifying protein which specifically reacts to serum of Crohn's disease patient through LC-ESI-MS analysis.
Abstract:
본발명은수지상세포성숙화유도조성물및 수지상세포를성숙시키는방법에관한것이다. 더욱구체적으로는결핵균(M. tuberculosis) 유래의 Rv2299c 또는 Rv2299c 와 ESAT-6를융합한단백질을유효성분으로포함하는수지상세포성숙화유도조성물및 이를이용하여미성숙수지상세포를수지상세포로분화시키는방법에관한것이다. 본발명의방법에의하여수지상세포에의한신체의면역반응을증강시킬수 있다.
Abstract:
본 발명은 수지상 세포 암 치료제에 관한 것이다. 더욱 구체적으로는 결핵균의 Rv0652를 아쥬반트로 이용한 수지상 세포 암 치료제에 관한 것이다. 본 발명의 결핵균의 Rv0652를 아쥬반트로 이용한 수지상 세포 암 치료제는 종양의 성장을 효과적으로 억제시킨다.
Abstract:
PURPOSE: A method for maturing dendritic cells is provided to promote differentiation of immature dendritic cells using Mycobacterium tuberculosis Rv2299c, to effectively mature the dendriric cells, and to effectively enhance immune response. CONSTITUTION: A composition for inducing maturation of dendritic cells contains 1-5 microgram/ml of Rv2299c protein derived from Mycobacterium tuberculosis as an active ingredient. A method for inducing maturation of immature dendritic cells comprises: a step of treating Rv2299c to the immature dendritic cells; and a step of culturing the treated dendritic cells for 12-36 hours. The maturation of the immature dendritic cells indicates enhancement of TNF-alpha, IL-12p70, IL-6, and IL-1beta.
Abstract:
PURPOSE: A method for maturing dendritic cells using Mycobacterium paratuberculosis MAP1948 is provided to promote the differentiation of immature dendritic cells and to effectively mature the dendritic cells. CONSTITUTION: A method for maturing dendritic cells using Mycobacterium paratuberculosis MAP1948 comprises: a step of treating immature resin cells with MAP1948; and a step of culturing the cell for 12-36 hours. The immature resin cells are matured through the increase of IL-6, IL-1beta, and IFN-gamma generation.
Abstract:
PURPOSE: A method for maturing dendritic cells using heparin binding hemagglutin(HBHA) is provided to effectively activate immune response. CONSTITUTION: A method for maturing dendritic cells comprises a step of treating 0.5-1.0 ug/ml of HBHA(heparin-binding hemagglutin) to immature dendritic cells and a step of culturing for 24 hours. The HBHA is a recombinant HBHA(rMS-HBHA) expressed in M. smegmatis.
Abstract:
PURPOSE: A specific protein for serological diagnosis for Crohn's disease is provided to specifically response to a serum from a patient with Crohn's disease. CONSTITUTION: A marker for diagnosing Crohn's disease contains TrpC(Indole-3-glycerolphosphate synthase) which is an antigen specifically responding to serum of Crohn's disease and is derived from human Mycobacterium avium subsp. Paratuberculosis. The marker also contains FbpC1(Fibronectin binding protein C1), FadB1(Fatty oxidation protein B1), LprG(Probable conserve lipoprotein LprG), Gap(Glyceraldehyde 3-phosphate dehydrogenase), Tpi(Triosephosphate isomerase), Tal(Transaldorase), aconitate hydratase, ArgJ(Arginine biosynthesis bifunctional protein), FbpB(Fibronectin binding protein B), HisG(Histidine synthesis protein G), Wag31(Conserved hypothetical protein), Mdh(Malate dehydrogenase), LppZ(Putative lipoprotein), or superoxide dismutase antigen. A composition or kit for diagnosing Crohn's disease contains the marker.
Abstract:
PURPOSE: A method for screening an antigen for diganosing nonturberculous acid-fast bacteria M. abscessus infection is provided. CONSTITUTION: A method for screening an antigen for diagnosing M. abscessus infection comprises: a step of infecting M. abscessus with epithelial cells or large phagocytes or infecting to epithelial cells and then large phagocytes; a step of confirming specifically expressed M. abscessus protein; a step of reacting the protein and serum from a patient with pulmonary diseases caused by M. abscessus infection; and a step of selecting and identifying the protein.